Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
+4.11M
-
Total reported value, excl. options
-
$321M
-
Value change
-
+$67M
-
Number of buys
-
55
-
Number of sells
-
-17
-
Price
-
$18.64
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2021
82 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q4 2021.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 63.2M outstanding shares and own 27.25% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (2.45M shares), VANGUARD GROUP INC (2.28M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.54M shares), BlackRock Inc. (1.52M shares), PERCEPTIVE ADVISORS LLC (980K shares), TimesSquare Capital Management, LLC (912K shares), JANUS HENDERSON GROUP PLC (666K shares), FMR LLC (596K shares), Novo Holdings A/S (500K shares), and Raymond James Financial Services Advisors, Inc. (470K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.